ENGOT/NSGO-CTU Collaborative studies
The European Network for Gynaecological Oncological Trial groups (ENGOT) is a research network of the European Society of Gynaecological Oncology (ESGO) and was founded in Berlin in October 2007.
Currently, ENGOT consists of 21 trial groups from 25 European countries that perform cooperative clinical trials.
ENGOT's ultimate goal is to bring the best treatment to gynaecological cancer patients through the best science, and enabling every patient in every European country to access a clinical trial.
NSGO-CTU is Clinical Trial Unit fo the the Nordic Society of Gynaeologocal Oncology and is the collaborating trial group of Danmark, Norway, Sweden, Finland, Lithuania and Estonia. As by March 2021, NSGO-CTU has been the leading group of 12 trials, and participated as collaboarying groups in 32 trials.
Dr. Mansoor Mirza is the deputy medical director of NSGO, Associate Prof. Kristina Lindemann and Dr. Kristina Madsen have been appointed Deputy Medical Director.
The National Advisory Unit of Gynecological Oncology led by A./Prof. Kristina Lindemann conducts numerous Phase II and III trials in collaboration with our international partners.
Please visit our web side:
An updated overview over recruiting studies in gynaecology oncology can be found: